Re-polarizing Myeloid-derived Suppressor Cells (MDSCs) with Cationic Polymers for Cancer Immunotherapy

Area of Science:

• Biomaterials Science
• Immunology
• Cancer Biology

Background:

• Myeloid-derived suppressor cells (MDSCs) promote tumor progression via an immunosuppressive M2 phenotype.
• Targeting MDSCs is a promising strategy for cancer immunotherapy.

Purpose of the Study:

• To investigate the potential of cationic polymers to modulate MDSC phenotype and function.
• To explore the therapeutic implications of polymer-mediated MDSC reprogramming in cancer.

Main Methods:

• Treatment of MDSCs with cationic dextran (C-dextran) and polyethyleneimine (PEI).
• Assessment of MDSC phenotype (M1 vs. M2) and cytokine production.
• Evaluation of T cell function and anti-tumour efficacy in a mouse model.
• Investigation of the role of toll-like receptor 4 (TLR4) signaling using knock-out mice.

Main Results:

• Cationic polymers directly remodeled MDSCs from an M2 to an M1 phenotype.
• Remodeled MDSCs exhibited enhanced expression of tumoricidal cytokines and reactivated T cell functions.
• Polymer treatment prolonged survival in a mouse cancer model.
• The anti-tumour effects were dependent on toll-like receptor 4-mediated signaling.

Conclusions:

• Cationic polymers effectively re-polarize immunosuppressive MDSCs to an anti-tumour phenotype.
• This approach restores immune surveillance within the tumor microenvironment, leading to tumor elimination.
• Findings support the development of polymer-based therapeutics for cancer immunotherapy.